Mortality From Respiratory Syncytial Virus in Children Under 2 Years of Age: A Prospective Community Cohort Study in Rural Maharashtra, India
Overview
Authors
Affiliations
Background: Although respiratory syncytial virus (RSV) is the most important viral cause of lower respiratory tract infection deaths in infants, there are few data on infant community deaths caused by RSV.
Methods: This was an active surveillance of children younger than 2 years of age in 93 villages, 5 primary health centers, and 3 hospitals serving these villages. Village health workers and counselors at the health facilities monitored all lower respiratory tract infections (LRTIs) in consented subjects. Children with severe, or very severe LRTIs and all who died, had nasopharyngeal swabs collected for detection of RSV by molecular methods.
Results: In the 12 134 subjects, there were 2064 episodes of severe LRTIs and 1732 of very severe LRTIs, of which 271 and 195, respectively, had RSV. Fifteen of 16 (94%) children with RSV died of LRTIs, 14 in the community and 1 in the hospital. The case fatality ratios for severe RSV LRTIs in the first 6 months of life were 3/52 (7.1%) and 1/36 (2.8%) in the community and hospital, respectively. Of those with very severe LRTIs in the community, 17.6% died. There were no very severe RSV LRTI hospital deaths. The adjusted RSV LRTI mortality rates ranged from 1.0 to 3.0/1000 child-years (CY) overall, and 2.0 to 6.1/1000 CY, accounting for 20% of the LRTI deaths and 10% of the postneonatal infant mortality.
Conclusions: Community deaths from RSV account for the majority of RSV LRTI deaths, and efforts at prevention should be preferentially directed at populations where access to care is limited.
Sini de Almeida R, Leite J, Atwell J, Elsobky M, LaRotta J, Mousa M Front Pediatr. 2024; 12:1452267.
PMID: 39639952 PMC: 11617186. DOI: 10.3389/fped.2024.1452267.
Dvorkin J, Sosa E, Vodicka E, Baral R, Sancilio A, Duenas K BMC Public Health. 2024; 24(1):427.
PMID: 38336643 PMC: 10858556. DOI: 10.1186/s12889-024-17878-3.
Satav A, Satav K, Kelkar A, Sahasrabhojaney V, Dani V, Raje D Indian J Med Res. 2023; 158(3):217-254.
PMID: 37861621 PMC: 10720956. DOI: 10.4103/ijmr.ijmr_3299_21.
Fitzpatrick M, Laufer R, Baral R, Driscoll A, Feikin D, Fleming J Vaccine. 2023; 41(48):7047-7059.
PMID: 37777450 PMC: 10680976. DOI: 10.1016/j.vaccine.2023.09.040.
Willemsen J, Borghans J, Bont L, Drylewicz J Vaccine X. 2023; 15:100379.
PMID: 37711264 PMC: 10498305. DOI: 10.1016/j.jvacx.2023.100379.